Biocon quarterly profit more than doubles to $30.54 million, beats estimate

Indian biotechnology firm Biocon Ltd`s quarterly profit more than doubled, handily beating analysts` estimates, largely driven by strong performance of its biologics businesses.

Profit rose to 2.17 billion rupees ($30.54 million) in the third quarter ended Dec. 31, compared with a profit of 919 million rupees a year earlier, the company said on Thursday.

Watch This Zee Business Video

TRENDING NOW

Weather Update: Heavy rains continue across Kerala; IMD issues 'yellow alert' in 13 districts

Finance Ministry notifies October 1 date for implementing amended GST law provisions for e-gaming

India, Argentina sign Social Security Agreement

Government increases windfall tax on domestic crude to Rs 12,100/t from Rs 10,000/t

BioAsia 2024 to discuss "Data and AI" to reshape future of life sciences

Auto giant Aston Martin launches DB12 in India; know ex-showroom price and specifications

Future growth options for Niva Bupa could include public listing of business

EPFO extends deadline to upload details by employers for higher pension option by 3-month till Dec 31

FPIs turned sustained sellers in September having sold stocks for Rs 26,689 crore

Amazon Great Indian Festival dates announced; Prime members to get early access from October 8

Dengue alarm: Centre asks Bengal to organise blood donation camps

Amazon Great Indian Festival: Get Apple iPhone 14 for as low as Rs 23,249

NPS vs APY: Can I have an account in the National Pension Scheme and Atal Pension Yojana at the same time?

Guaranteed Pension System (GPS) vs Old Pension Scheme (OPS): Which pension scheme offers maximum retirement benefits?

Credit Card: I have no income proof; can a bank issue me a credit card?

Nine analysts on an average had expected a profit of 1.76 billion rupees, according to Refinitiv Eikon data. Revenue from operations grew 45.6 percent to 154.08 billion rupees, while revenue from its biologics segment more than doubled.($1 = 71.0580 Indian rupees)